Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harpoon Therapeutics Inc (NQ: HARP )

0.8000 +0.1152 (+16.82%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 691,453
Open 0.6900
Bid (Size) 0.7900 (20)
Ask (Size) 0.8370 (1)
Prev. Close 0.6848
Today's Range 0.6650 - 0.8390
52wk Range 0.5440 - 3.355
Shares Outstanding 37,595,787
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Harpoon Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Harpoon Therapeutics
Via GlobeNewswire
Short Volatility Alert: Harpoon Therapeutics
On Thursday, shares of Harpoon Therapeuti (NASDAQ: HARP) experienced volatile short activity. After the activity, the stock price went down -1.59% to $0.62. The overall sentiment for HARP has been... 
Via Benzinga

Performance

YTD
+12.68%
+12.68%
1 Month
+45.45%
+45.45%
3 Month
+2.42%
+2.42%
6 Month
+8.25%
+8.25%
1 Year
-59.60%
-59.60%

More News

Read More
Harpoon Therapeutics Presents Preclinical Results for Novel T Cell Engagers HPN217 and HPN328 at AACR 2023
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics Presents Data for New ProTriTAC™ Development Candidates in TROP2- and ITGB6-expressing Solid Tumors at AACR 2023
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics to Participate in the Canaccord Horizons in Oncology Conference
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics Announces Closing of $25 Million Private Placement
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023
From Harpoon Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Harpoon Therapeutics to Participate in the SVB Securities Global Biopharma Conference
From Harpoon Therapeutics
Via GlobeNewswire
The 3 Most Undervalued Penny Stocks to Buy in February 2023
Via InvestorPlace
Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why CN Energy Group Shares Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
MarketBeat: Week in Review 12/12 - 12/16
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
7 Stocks to Add to Your 10x Watchlist
Via InvestorPlace
Harpoon Therapeutics Remains Volatile After Promising News
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.